Raleigh Hankins

672 total citations
18 papers, 538 citations indexed

About

Raleigh Hankins is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, Raleigh Hankins has authored 18 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Hepatology and 4 papers in Rheumatology. Recurrent topics in Raleigh Hankins's work include Liver Disease Diagnosis and Treatment (6 papers), Liver Diseases and Immunity (5 papers) and Respiratory viral infections research (2 papers). Raleigh Hankins is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Liver Diseases and Immunity (5 papers) and Respiratory viral infections research (2 papers). Raleigh Hankins collaborates with scholars based in Japan, Canada and Denmark. Raleigh Hankins's co-authors include Peter Bjerring, Seiji Kawana, Kiyomitsu Miyachi, Hiroshi Miyakawa, Hiroshi Matsushima, Aya Ihara, Hiroyuki Miyashita, Mitsuyoshi Honda, Shigeru Sato and Tokuya Omi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Microbiology and British Journal of Dermatology.

In The Last Decade

Raleigh Hankins

18 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raleigh Hankins Japan 12 156 120 118 117 104 18 538
F. Mollica Italy 15 72 0.5× 231 1.9× 21 0.2× 67 0.6× 90 0.9× 70 677
Shashi Anand India 11 76 0.5× 44 0.4× 34 0.3× 116 1.0× 31 0.3× 44 375
M. Simon France 14 97 0.6× 262 2.2× 45 0.4× 88 0.8× 20 0.2× 31 1.2k
Sylvie Blazejewski France 11 205 1.3× 97 0.8× 257 2.2× 41 0.4× 36 0.3× 16 468
Takumi Tsuji Japan 11 67 0.4× 157 1.3× 54 0.5× 27 0.2× 10 0.1× 31 414
Masashi Ishikawa Japan 15 103 0.7× 191 1.6× 43 0.4× 23 0.2× 9 0.1× 47 728
Ann E. Kelly-Welch United States 9 56 0.4× 185 1.5× 18 0.2× 36 0.3× 13 0.1× 10 672
A. Dimitrakopoulos Greece 14 82 0.5× 139 1.2× 53 0.4× 53 0.5× 4 0.0× 30 658
Masamichi Kimura Japan 14 103 0.7× 209 1.7× 77 0.7× 18 0.2× 29 0.3× 38 533
Mahdi Zamani Iran 14 41 0.3× 84 0.7× 12 0.1× 40 0.3× 94 0.9× 44 603

Countries citing papers authored by Raleigh Hankins

Since Specialization
Citations

This map shows the geographic impact of Raleigh Hankins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raleigh Hankins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raleigh Hankins more than expected).

Fields of papers citing papers by Raleigh Hankins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raleigh Hankins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raleigh Hankins. The network helps show where Raleigh Hankins may publish in the future.

Co-authorship network of co-authors of Raleigh Hankins

This figure shows the co-authorship network connecting the top 25 collaborators of Raleigh Hankins. A scholar is included among the top collaborators of Raleigh Hankins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raleigh Hankins. Raleigh Hankins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Miyachi, Kiyomitsu, et al.. (2011). Comparison of the efficacies of amantadine treatment of swine-origin influenza virus A H1N1 and seasonal influenza H1N1 and H3N2 in Japan (2008–2009). Journal of Infection and Chemotherapy. 17(4). 524–529. 5 indexed citations
2.
3.
Miyachi, Kiyomitsu, et al.. (2007). Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjögren's syndrome and other systemic rheumatic diseases. Modern Rheumatology. 17(2). 137–143. 12 indexed citations
4.
5.
Miyachi, Kiyomitsu, Noriko Nakamura, Hiroshi Miyakawa, et al.. (2006). Anti‐p97/VCP Antibodies: An Autoantibody Marker for a Subset of Primary Biliary Cirrhosis Patients with Milder Disease?. Scandinavian Journal of Immunology. 63(5). 376–382. 20 indexed citations
6.
Omi, Toshinori, Seiji Kawana, Shigeru Sato, et al.. (2005). Cutaneous immunological activation elicited by a low-fluence pulsed dye laser. British Journal of Dermatology. 153(s2). 57–62. 48 indexed citations
7.
Miyachi, Kiyomitsu, Yasuhiro Hirano, Tsuneyo Mimori, et al.. (2004). Autoantibodies from primary biliary cirrhosis patients with anti-p95c antibodies bind to recombinant p97/VCP and inhibitin vitronuclear envelope assembly. Clinical & Experimental Immunology. 136(3). 568–573. 22 indexed citations
8.
Omi, Tokuya, Peter Bjerring, Shigeru Sato, et al.. (2004). 420 nm intense continuous light therapy for acne. Journal of Cosmetic and Laser Therapy. 6(3). 156–162. 62 indexed citations
9.
Oshikawa, Jin, Yoshiyuki Toya, Takashi Tsunematsu, et al.. (2004). Insulin resistance in skeletal muscles of caveolin-3-null mice. Proceedings of the National Academy of Sciences. 101(34). 12670–12675. 82 indexed citations
10.
Ihara, Aya, et al.. (2003). Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemia. Clinical Rheumatology. 22(4-5). 329–332. 57 indexed citations
11.
Miyachi, Kiyomitsu, Raleigh Hankins, Hiroshi Matsushima, et al.. (2003). Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. Journal of Autoimmunity. 20(3). 247–254. 74 indexed citations
12.
Miyachi, Kiyomitsu, et al.. (2002). Prospective study of a systemic sclerosis/dermatomyositis overlap patient presenting with anti-Ku and anti-Ki antibodies. Modern Rheumatology. 12(3). 253–255. 2 indexed citations
14.
Igarashi, Toshiko, et al.. (2001). Differences in Anti-LKM-1 Autoantibody Immunoreactivity to CYP2D6 Antigenic Sites Between Hepatitis C Virus-negative and -positive Patients. Journal of Autoimmunity. 17(3). 243–249. 17 indexed citations
15.
Miyakawa, Hiroshi, Kentaro Kikuchi, Hirotoshi Fujikawa, et al.. (2001). Immunoreactivity to Various Human Cytochrome P450 Proteins of Sera from Patients with Autoimmune Hepatitis, Chronic Hepatitis B, and Chronic Hepatitis C. Autoimmunity. 33(1). 23–32. 29 indexed citations
16.
Miyakawa, Hiroshi, Hiroshi Matsushima, Raleigh Hankins, et al.. (1998). Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients. Journal of Gastroenterology. 33(4). 529–535. 4 indexed citations
17.
Hankins, Raleigh, Kyosuke Nagata, Atsushi Kato, & Akira Ishihama. (1990). Mechanism of influenza virus transcription inhibition by matrix (M1) protein. Research in Virology. 141(3). 305–314. 25 indexed citations
18.
Hankins, Raleigh & Francis L. Black. (1986). Western blot analyses of measles virus antibody in normal persons and in patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles. Journal of Clinical Microbiology. 24(3). 324–329. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026